第一章 冠心病血瘀證病證結(jié)合研究
冠心病血瘀證診斷標(biāo)準(zhǔn)研究
冠心病血瘀證血小板差異功能蛋白篩選、鑒定及功能分析
冠心病穩(wěn)定期血瘀證與冠狀動脈病變特點的相關(guān)性
冠心病差異基因表達譜的構(gòu)建及目標(biāo)基因的功能分析
漢族人血小板膜糖蛋白Ⅲa PLA基因多態(tài)性與冠心病血瘀證的相關(guān)性
漢族人血小板GPⅡb HPA-3基因多態(tài)性與冠心病的相關(guān)性研究
Correlation between Platelet Gelsolin Levels and Different Types of Coronary Heart Disease
Research on the Correlation between Platelet Gelsolin and Blood-Stasis Syndrome of Coronary Heart Disease
Aberrant Expression of FcγRⅡA (CD 16) Contributes to the Development of Atherosclerosis
Investigation of Gene Expression Profiles in Coronary Heart Disease and Functional Analysis of Target Gene
Differential Gene Expression Profiles in Coronary Heart Disease Patients of Blood
Stasis Syndrome in Traditional Chinese Medicine and Clinical Role of Target Gene
第二章 心血管瘀毒病因?qū)W研究
冠心病穩(wěn)定期因毒致病的辨證診斷量化標(biāo)準(zhǔn) 第一章  冠心病血瘀證病證結(jié)合研究
  冠心病血瘀證診斷標(biāo)準(zhǔn)研究
  冠心病血瘀證血小板差異功能蛋白篩選、鑒定及功能分析
  冠心病穩(wěn)定期血瘀證與冠狀動脈病變特點的相關(guān)性
  冠心病差異基因表達譜的構(gòu)建及目標(biāo)基因的功能分析
  漢族人血小板膜糖蛋白Ⅲa PLA基因多態(tài)性與冠心病血瘀證的相關(guān)性
  漢族人血小板GPⅡb HPA-3基因多態(tài)性與冠心病的相關(guān)性研究
  Correlation between Platelet Gelsolin Levels and Different Types of Coronary Heart Disease
  Research on the Correlation between Platelet Gelsolin and Blood-Stasis Syndrome of Coronary Heart Disease
  Aberrant Expression of FcγRⅡA (CD 16) Contributes to the Development of Atherosclerosis
  Investigation of Gene Expression Profiles in Coronary Heart Disease and Functional Analysis of Target Gene
  Differential Gene Expression Profiles in Coronary Heart Disease Patients of Blood
  Stasis Syndrome in Traditional Chinese Medicine and Clinical Role of Target Gene
第二章  心血管瘀毒病因?qū)W研究
  冠心病穩(wěn)定期因毒致病的辨證診斷量化標(biāo)準(zhǔn)
  冠心病穩(wěn)定期“瘀毒”臨床表征的研究
  活血解毒中藥配伍干預(yù)介入后不穩(wěn)定型心絞痛的臨床研究
  活血解毒中藥對穩(wěn)定期冠心病患者血清炎癥標(biāo)記物及血脂的影響
  Study on the Tongue Manifestations for the Blood-Stasis and Toxin Syndrome in the Stable Patients of Coronary Heart Disease
  A New Potential Biomarker of "Toxin Syndrome" in Coronary Heart Disease Patient Identified with Proteomic Method
第三章  中西醫(yī)結(jié)合防治心血管病的臨床研究
  第一節(jié) 中西醫(yī)結(jié)合防治冠心病心絞痛
  芎芍膠囊治療冠心病心絞痛心血瘀阻證112例臨床研究
  冠心病住院患者心血管事件的發(fā)生與中醫(yī)證候分布規(guī)律研究
  冠心病穩(wěn)定期患者中醫(yī)辨證與超敏C反應(yīng)蛋白相關(guān)性研究
  用復(fù)雜網(wǎng)絡(luò)挖掘分析冠心病證候-治法-中藥的關(guān)系
  急性冠狀動脈綜合征中醫(yī)證候要素分析
  Analysis on Outcome of 5284 Patients with Coronary Artery Disease: The Role of Integrative Medicine
  The Significant Increase of FcγR Ill A (CD16), A Sensitive Marker, in Patients with Coronary Heart Disease
  The Expression of CD14+CD16~ Monocyte Subpopulation in Coronary Heart Disease Patients with Blood Stasis Syndrome
  Combination of Chinese Herbal Medicines and Conventional Treatment versus Conventional Treatment Alone in Patients with Acute Coronary Syndrome after Percu-
  taneous Coronary Intervention (5C trial) : An Open-Label Randomized Controlled, Multicenter Study
  Analysis on Outcome of 3537 Patients with Coronary Artery Disease: Integrative Medicine for Cardiovascular Events
  The Effect of Sodium Tanshinone ⅡA Sulfate and Simvastatin on Elevated Serum
  Levels of Inflammatory Markers in Patients with Coronary Heart Disease: Study Protocol for a Randomized Controlled Trial
  第二節(jié) 中西醫(yī)結(jié)合防治心肌梗死及介入術(shù)后干預(yù)
  益氣養(yǎng)陰活血中藥對急性心肌梗死患者血運重建后心室壁運動的影響
  Protective Effect of Chinese Herbs for Supplementing Qi, Nourishing Yin and Activating Blood Circulation on Heart Function of Patients with Acute Coronary
   Syndrome after Percutaneous Coronary Intervention
  Clinical Outcomes and Cost-Utility after Sirolimus-Eluting versus Bare Metal Stent Implantation
  A Multi-Center Randomized Double-Blind Placebo-Controlled Trial of Xiongshao
  Capsule in Preventing Restenosis after Percutaneous Coronary Intervention: A
  Subgroup Analysis of Senile Patients
  Clinical Efficacy of Traditional Chinese Medicine on Acute Myocardial Infarction--A Prospective Cohort Study
……
第三章  中西醫(yī)結(jié)合防治心血管病的臨床研究
第四章  中醫(yī)藥防治心血管疾病的藥理研究
第五章  糖、脂代謝異常的相關(guān)研究及其他
第六章  名老中醫(yī)經(jīng)驗繼承
第七章  綜述與系統(tǒng)評價